Addressing Challenges in Cell Therapy Manufacturing
Singapore, April 1 -- Even with significant advancements, there are still a number of issues with cell therapy manufacturing that need to be resolved as production grows.
Cancer research has come a long way. Along with technology advancements, the basic options for treating cancer, such as surgery, radiation, and chemotherapy, have expanded their mainstays when immunotherapy is developed. Individualised CAR-T cell therapy uses a patient's immune system to fight specific types of cancers or a broad spectrum of immuno-oncology and infectious diseases. Cell-based therapies aim to treat diseases by altering or restoring certain sets of cells or using cells to carry a therapy through the body.
Despite substantial progress in this field, cel...
Click here to read full article from source
To read the full article or to get the complete feed from this publication, please
Contact Us.